CGEM
Price
$18.06
Change
+$0.18 (+1.01%)
Updated
Apr 18, 6:59 PM EST
21 days until earnings call
MBIO
Price
$0.37
Change
-$0.01 (-2.63%)
Updated
Apr 18, 6:59 PM EST
Ad is loading...

Analysis and predictions CGEM vs MBIO

Header iconCGEM vs MBIO Comparison
Open Charts CGEM vs MBIOBanner chart's image
Cullinan Oncology
Price$18.06
Change+$0.18 (+1.01%)
Volume$411.85K
CapitalizationN/A
Mustang Bio
Price$0.37
Change-$0.01 (-2.63%)
Volume$142.36K
CapitalizationN/A
View a ticker or compare two or three
CGEM vs MBIO Comparison Chart

Loading...

CGEMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MBIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CGEM vs. MBIO commentary
Apr 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a StrongBuy and MBIO is a Hold.

COMPARISON
Comparison
Apr 19, 2024
Stock price -- (CGEM: $17.88 vs. MBIO: $0.38)
Brand notoriety: CGEM and MBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 266% vs. MBIO: 176%
Market capitalization -- CGEM: $768.29M vs. MBIO: $3.99M
CGEM [@Biotechnology] is valued at $768.29M. MBIO’s [@Biotechnology] market capitalization is $3.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $551.2B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileMBIO’s FA Score has 0 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • MBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, CGEM is a better buy in the long-term than MBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 5 TA indicator(s) are bullish while MBIO’s TA Score has 4 bullish TA indicator(s).

  • CGEM’s TA Score: 5 bullish, 4 bearish.
  • MBIO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CGEM is a better buy in the short-term than MBIO.

Price Growth

CGEM (@Biotechnology) experienced а +4.81% price change this week, while MBIO (@Biotechnology) price change was -26.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.57%. For the same industry, the average monthly price growth was -2.16%, and the average quarterly price growth was +1228.07%.

Reported Earning Dates

CGEM is expected to report earnings on Aug 08, 2024.

MBIO is expected to report earnings on May 12, 2023.

Industries' Descriptions

@Biotechnology (-7.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CGEM with price predictions.
OPEN
A.I.dvisor published
a Summary for MBIO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CGEM($768M) has a higher market cap than MBIO($3.99M). CGEM YTD gains are higher at: 75.466 vs. MBIO (-71.556).
CGEMMBIOCGEM / MBIO
Capitalization768M3.99M19,248%
EBITDAN/AN/A-
Gain YTD75.466-71.556-105%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
MBIO: Fundamental Ratings
MBIO
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGEMMBIO
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 18 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CGEMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MBIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BBTGX27.00-0.09
-0.33%
Sterling Capital Behav Lg Cp Val Eq A
TNBRX16.98-0.06
-0.35%
1290 SmartBeta Equity R
RGDTX9.70-0.04
-0.41%
Russell Inv Global Equity M
BMSDX13.67-0.06
-0.44%
MFS Blended Research Mid Cap Eq C
NBGIX59.89-0.74
-1.22%
Neuberger Berman Genesis Instl

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with MDGL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
+3.23%
MDGL - CGEM
50%
Loosely correlated
-1.99%
GOSS - CGEM
45%
Loosely correlated
-0.10%
ORMP - CGEM
42%
Loosely correlated
-2.92%
FATE - CGEM
38%
Loosely correlated
-2.04%
FOLD - CGEM
37%
Loosely correlated
-0.09%
More

MBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBIO has been loosely correlated with MDGL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MBIO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBIO
1D Price
Change %
MBIO100%
+10.92%
MDGL - MBIO
50%
Loosely correlated
-1.99%
ORMP - MBIO
44%
Loosely correlated
-2.92%
AXON - MBIO
40%
Loosely correlated
-0.16%
CYTK - MBIO
38%
Loosely correlated
-1.55%
VERA - MBIO
33%
Loosely correlated
-6.01%
More